Listed Companies > Listed Companies Info. > Main Board Companies > Listed Company Profile
General Stock Board Listed Company Profile
Local/Foreign Company:
6472 Bora
Company Profile
Chairman CEO Spokesperson Tel Address Date of Listing (Regular)
PAO-SHI, SHENG PAO-SHI, SHENG SHIH-MIN, CHEN (02)27901555 6F., No.69, Xing’ai Rd.Neihu Dist., Taipei City 114, Taiwan 2017/04/19
Industry Main Business
Biotechnology and Medical Care
Bora Pharmaceuticals is one of the premier pharmaceutical companies in Taiwan. We are one of the few companies that cover the entire pharmaceutical supply chain from research and development all the way to sales and distribution. Bora Pharmaceuticals has an extremely solid financial foundation and experienced management team, but also is continually pushing the boundaries of research and innovation. We have long standing partnerships with best in class multinationals such as Eisai, Lundbeck, Boehringer Ingelheim, and Amneal. Our internal business units range from a research and development, production, and in market sales and distribution. We also provide outsourced R&D and toll manufacturing services for domestic and multinational pharmaceutical companies. With Bora's US FDA certified Hsinchu plant and PIC/S certified Tainan Plant, we produce pharmaceuticals at the highest international standards and also export to over 15 counties worldwide.
Market Information ( 2020/08/10 )
Shr. Vol. Highest Lowest Closed Change Transaction TurnOver(%) long
117.437 155.00  151.50  152.00  -3.50  116 0.28 938 4
Trading method Fun
price or
on T day
Announcement of Irregularity
TPEx measures
With warrants Can be shorted or margined? Detail
Normal N N N N Y Today History
Financial Reports
Cash Flows Items
(NT$ thousand)
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Total liabilities
Share capital
Capital surplus
Retained earnings
Other equity interest
Treasury shares
Total equity attributable to owners of parent
Non-controlling interests
Total equity
Book Value per share(NT$)
Comprehensive Income Operating revenue
Operating costs
Gross profit from operations
Operating expenses
Net other income (expenses)
Net operating income
Non-operating income and expenses
Profit before tax
Tax expense
Profit from continuing operations
Profit from discontinued operations
Other comprehensive income
Comprehensive income
Basic earnings per share
* Auditor's report on latest financial statements: auditor's report:
* More detail:MOPS
* Foreign issuers’ information is disclosed in consolidated statements.